Literature DB >> 15706060

tNOX is both necessary and sufficient as a cellular target for the anticancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate.

Pin-Ju Chueh1, Lian-Ying Wu, Dorothy M Morré, D James Morré.   

Abstract

Capsaicin and the principal green tea catechin, (-)-epigallocatechin-3-gallate (EGCg), target tNOX, a tumor (cancer)-specific surface hydroquinone (NADH) oxidase with protein disulfide-thiol interchange activity (ECTO-NOX protein). Accordingly vector-forced over expression of tNOX in MCF-10A mammary epithelia or COS cells that lack tNOX or in COS cells that underexpress tNOX enhanced the susceptibility of growth and apoptosis to both EGCg and capsaicin. Additionally, the tNOX-transfected MCF-10A cells proliferated in Matrigel, a measure of invasiveness. In contrast, oligomeric antisense tNOX DNA abrogated growth inhibition by EGCg and capsaicin and reduced anchorage-dependent growth of HeLa (human cervical carcinoma) cells that naturally overexpress tNOX. The findings show cell surface expression of tNOX as both necessary and sufficient for the cellular anticancer activities attributed to both EGCg and capsaicin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15706060

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  13 in total

Review 1.  Botanicals for age-related diseases: from field to practice.

Authors:  Connie M Weaver; Stephen Barnes; J Michael Wyss; Helen Kim; Dorothy M Morré; D James Morré; James E Simon; Mary Ann Lila; Elsa M Janle; Mario G Ferruzzi
Journal:  Am J Clin Nutr       Date:  2008-02       Impact factor: 7.045

2.  hnRNP F directs formation of an exon 4 minus variant of tumor-associated NADH oxidase (ENOX2).

Authors:  Xiaoyu Tang; Vanessa D Kane; Dorothy M Morré; D James Morré
Journal:  Mol Cell Biochem       Date:  2011-05-28       Impact factor: 3.396

3.  tNOX, an alternative target to COX-2 to explain the anticancer activities of non-steroidal anti-inflammatory drugs (NSAIDS).

Authors:  D James Morré; Dorothy M Morre
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

Review 4.  Update on a tumor-associated NADH oxidase in gastric cancer cell growth.

Authors:  Hsiao-Ling Cheng; Yi-Hui Lee; Tein-Ming Yuan; Shi-Wen Chen; Pin-Ju Chueh
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

5.  Homocysteine is a potent modulator of plasma membrane electron transport systems.

Authors:  Javier Rodríguez-Alonso; Raúl Montañez; Luis Rodríguez-Caso; Miguel Angel Medina
Journal:  J Bioenerg Biomembr       Date:  2008-01-24       Impact factor: 2.945

6.  Research Highlights from the Purdue-UAB Botanicals Research Center for Age Related Diseases.

Authors:  Connie M Weaver; Stephen Barnes; J Michael Wyss; Helen Kim; Dorothy M Morré; D James Morré; James E Simon; Mary Ann Lila; Elsa M Janle; Mario G Ferruzzi
Journal:  Pharm Biol       Date:  2009-08-01       Impact factor: 3.503

7.  Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicin.

Authors:  Laurent Schwartz; Adeline Guais; Maurice Israël; Bernard Junod; Jean-Marc Steyaert; Elisabetta Crespi; Gianfranco Baronzio; Mohammad Abolhassani
Journal:  Invest New Drugs       Date:  2012-07-14       Impact factor: 3.850

8.  Cancer prevention trial of a synergistic mixture of green tea concentrate plus Capsicum (CAPSOL-T) in a random population of subjects ages 40-84.

Authors:  Claudia Hanau; D James Morré; Dorothy M Morré
Journal:  Clin Proteomics       Date:  2014-01-06       Impact factor: 3.988

9.  Tumor-associated NADH oxidase (tNOX)-NAD+-sirtuin 1 axis contributes to oxaliplatin-induced apoptosis of gastric cancer cells.

Authors:  Huei-Yu Chen; Hsiao-Ling Cheng; Yi-Hui Lee; Tien-Ming Yuan; Shi-Wen Chen; You-Yu Lin; Pin Ju Chueh
Journal:  Oncotarget       Date:  2017-02-28

Review 10.  SIRT1 in the Development and Treatment of Hepatocellular Carcinoma.

Authors:  Marius Farcas; Andrei-Alexandru Gavrea; Diana Gulei; Calin Ionescu; Alexandru Irimie; Cristina S Catana; Ioana Berindan-Neagoe
Journal:  Front Nutr       Date:  2019-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.